Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus

Marc G. Weisskopf, Howard Hu, David Sparrow, Robert E. Lenkinski, Robert O. Wright

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Exposure to lead is known to have adverse effects on cognition in several different populations. Little is known about the underlying structural and functional correlates of such exposure in humans. Objectives: We assessed the association between cumulative exposure to lead and levels of different brain metabolite ratios in vivo using magnetic resonance spectroscopy (MRS). Methods: We performed MRS on 15 men selected from the lowest quintile of patella bone lead within the Department of Veterans Affairs' Normative Aging Study (NAS) and 16 from the highest to assess in the hippocampal levels of the metabolites N-acetylaspartate, myoinositol, and choline, each expressed as a ratio with creatine. Bone lead concentrations - indicators of cumulative lead exposure - were previously measured using K-X-ray fluorescence spectroscopy. MRS was performed on the men from 2002 to 2004. Results: A 20-μg/g bone and 15-μg/g bone higher patella and tibia bone lead concentration - the respective interquartile ranges within the whole NAS - were associated with a 0.04 [95% confidence interval (CI), 0.00-0.08; p = 0.04] and 0.04 (95% CI, 0.00-0.08; p = 0.07) higher myoinositol-to-creatine ratio in the hippocampus. After accounting for patella bone lead declines over time, analyses adjusted for age showed that the effect of a 20-μg/g bone higher patella bone lead level doubled (0.09; 95% CI, 0.01-0.17; p = 0.03). Conclusions: Cumulative lead exposure is associated with an increase in the myinositol-to-creatine ratio. These data suggest that, as assessed with MRS, glial effects may be more sensitive than neuronal effects as an indicator of cumulative exposure to lead in adults.

Original languageEnglish (US)
Pages (from-to)519-523
Number of pages5
JournalEnvironmental Health Perspectives
Volume115
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Neuroglia
Protons
bone
Hippocampus
Bone
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
Magnetic resonance spectroscopy
Bone and Bones
Patella
Creatine
spectroscopy
confidence interval
Inositol
Confidence Intervals
Metabolites
metabolite
Aging of materials
X-Ray Emission Spectrometry
fluorescence spectroscopy

Keywords

  • Bone lead
  • Choline
  • Glia
  • Hippocampus
  • Myoinositol
  • N-acetylaspartate
  • Neuronal viability
  • Proton MRS

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus. / Weisskopf, Marc G.; Hu, Howard; Sparrow, David; Lenkinski, Robert E.; Wright, Robert O.

In: Environmental Health Perspectives, Vol. 115, No. 4, 04.2007, p. 519-523.

Research output: Contribution to journalArticle

@article{cfa543a6d61549cd9e146652435102d3,
title = "Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus",
abstract = "Background: Exposure to lead is known to have adverse effects on cognition in several different populations. Little is known about the underlying structural and functional correlates of such exposure in humans. Objectives: We assessed the association between cumulative exposure to lead and levels of different brain metabolite ratios in vivo using magnetic resonance spectroscopy (MRS). Methods: We performed MRS on 15 men selected from the lowest quintile of patella bone lead within the Department of Veterans Affairs' Normative Aging Study (NAS) and 16 from the highest to assess in the hippocampal levels of the metabolites N-acetylaspartate, myoinositol, and choline, each expressed as a ratio with creatine. Bone lead concentrations - indicators of cumulative lead exposure - were previously measured using K-X-ray fluorescence spectroscopy. MRS was performed on the men from 2002 to 2004. Results: A 20-μg/g bone and 15-μg/g bone higher patella and tibia bone lead concentration - the respective interquartile ranges within the whole NAS - were associated with a 0.04 [95{\%} confidence interval (CI), 0.00-0.08; p = 0.04] and 0.04 (95{\%} CI, 0.00-0.08; p = 0.07) higher myoinositol-to-creatine ratio in the hippocampus. After accounting for patella bone lead declines over time, analyses adjusted for age showed that the effect of a 20-μg/g bone higher patella bone lead level doubled (0.09; 95{\%} CI, 0.01-0.17; p = 0.03). Conclusions: Cumulative lead exposure is associated with an increase in the myinositol-to-creatine ratio. These data suggest that, as assessed with MRS, glial effects may be more sensitive than neuronal effects as an indicator of cumulative exposure to lead in adults.",
keywords = "Bone lead, Choline, Glia, Hippocampus, Myoinositol, N-acetylaspartate, Neuronal viability, Proton MRS",
author = "Weisskopf, {Marc G.} and Howard Hu and David Sparrow and Lenkinski, {Robert E.} and Wright, {Robert O.}",
year = "2007",
month = "4",
doi = "10.1289/ehp.9645",
language = "English (US)",
volume = "115",
pages = "519--523",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "4",

}

TY - JOUR

T1 - Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus

AU - Weisskopf, Marc G.

AU - Hu, Howard

AU - Sparrow, David

AU - Lenkinski, Robert E.

AU - Wright, Robert O.

PY - 2007/4

Y1 - 2007/4

N2 - Background: Exposure to lead is known to have adverse effects on cognition in several different populations. Little is known about the underlying structural and functional correlates of such exposure in humans. Objectives: We assessed the association between cumulative exposure to lead and levels of different brain metabolite ratios in vivo using magnetic resonance spectroscopy (MRS). Methods: We performed MRS on 15 men selected from the lowest quintile of patella bone lead within the Department of Veterans Affairs' Normative Aging Study (NAS) and 16 from the highest to assess in the hippocampal levels of the metabolites N-acetylaspartate, myoinositol, and choline, each expressed as a ratio with creatine. Bone lead concentrations - indicators of cumulative lead exposure - were previously measured using K-X-ray fluorescence spectroscopy. MRS was performed on the men from 2002 to 2004. Results: A 20-μg/g bone and 15-μg/g bone higher patella and tibia bone lead concentration - the respective interquartile ranges within the whole NAS - were associated with a 0.04 [95% confidence interval (CI), 0.00-0.08; p = 0.04] and 0.04 (95% CI, 0.00-0.08; p = 0.07) higher myoinositol-to-creatine ratio in the hippocampus. After accounting for patella bone lead declines over time, analyses adjusted for age showed that the effect of a 20-μg/g bone higher patella bone lead level doubled (0.09; 95% CI, 0.01-0.17; p = 0.03). Conclusions: Cumulative lead exposure is associated with an increase in the myinositol-to-creatine ratio. These data suggest that, as assessed with MRS, glial effects may be more sensitive than neuronal effects as an indicator of cumulative exposure to lead in adults.

AB - Background: Exposure to lead is known to have adverse effects on cognition in several different populations. Little is known about the underlying structural and functional correlates of such exposure in humans. Objectives: We assessed the association between cumulative exposure to lead and levels of different brain metabolite ratios in vivo using magnetic resonance spectroscopy (MRS). Methods: We performed MRS on 15 men selected from the lowest quintile of patella bone lead within the Department of Veterans Affairs' Normative Aging Study (NAS) and 16 from the highest to assess in the hippocampal levels of the metabolites N-acetylaspartate, myoinositol, and choline, each expressed as a ratio with creatine. Bone lead concentrations - indicators of cumulative lead exposure - were previously measured using K-X-ray fluorescence spectroscopy. MRS was performed on the men from 2002 to 2004. Results: A 20-μg/g bone and 15-μg/g bone higher patella and tibia bone lead concentration - the respective interquartile ranges within the whole NAS - were associated with a 0.04 [95% confidence interval (CI), 0.00-0.08; p = 0.04] and 0.04 (95% CI, 0.00-0.08; p = 0.07) higher myoinositol-to-creatine ratio in the hippocampus. After accounting for patella bone lead declines over time, analyses adjusted for age showed that the effect of a 20-μg/g bone higher patella bone lead level doubled (0.09; 95% CI, 0.01-0.17; p = 0.03). Conclusions: Cumulative lead exposure is associated with an increase in the myinositol-to-creatine ratio. These data suggest that, as assessed with MRS, glial effects may be more sensitive than neuronal effects as an indicator of cumulative exposure to lead in adults.

KW - Bone lead

KW - Choline

KW - Glia

KW - Hippocampus

KW - Myoinositol

KW - N-acetylaspartate

KW - Neuronal viability

KW - Proton MRS

UR - http://www.scopus.com/inward/record.url?scp=34247157382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247157382&partnerID=8YFLogxK

U2 - 10.1289/ehp.9645

DO - 10.1289/ehp.9645

M3 - Article

VL - 115

SP - 519

EP - 523

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 4

ER -